Protein farnesyltransferase (FTase) 1 catalyzes the transfer of a 15-carbon farnesyl chain from farnesyl diphosphate (FPP) to a C-terminal cysteine sulfur of protein substrates in the cell (1). Protein or peptide substrates of FTase contain a C-terminal CaaX sequence, whereas C represents the cysteine that becomes farnesylated, a 1 and a 2 are typically small aliphatic amino acids, and X is commonly methionine, serine, glutamine, or alanine (2). FTase is known to modify several important proteins in the cell cycle machinery, including Ras, Rho B, CENP-E, and CENP-F (3). Farnesylation of proteins enhances membrane association and specific protein-protein interactions and therefore is thought to be important for localization of proteins in the cell (4 -6). After farnesylation by FTase, proteins are further processed by the CaaX protease Rce1 and the methyltransferase Icmt, producing a Cterminal farnesylated cysteine methyl ester as the end product of this pathway (7,8). Protein farnesyltransferase inhibitors are currently being evaluated in clinical trials for the treatment of several types of cancer, including acute myeloid leukemia, metastatic breast cancer, and non-small cell lung cancer (9, 10).Farnesylation is just one type of protein prenylation; proteins can also be modified with geranylgeranyl groups in a reaction catalyzed by geranylgeranyl transferase type I or type II (GGTase I and GGTase II) (11, 12). GGTase I also recognizes protein substrates with a C-terminal CaaX motif, but GGTase I substrates most frequently contain a leucine or phenylalanine at the X position (13, 14). FTase and GGTase I are structurally homologous heterodimers with identical ␣ subunits and differing  subunits (15). Prenyltransferases contain an active site zinc ion that is required for activity; FTase and GGTase II also use a magnesium ion to facilitate catalysis (16 -19). Surprisingly, GGTase I apparently catalyzes the same prenyl transfer reaction with no dependence on magnesium ions (20).In FTase, the magnesium ion has been proposed to coordinate to the diphosphate of FPP, but the exact location of the magnesium binding site has not yet been identified (21). The bound zinc ion of FTase coordinates to the cysteine sulfur of the protein substrate, lowering the pK a to form a zincthiolate at neutral pH (22, 23). In the proposed farnesylation transition state of FTase (Scheme 1), positive charge accumulates on the C-1 of FPP, and the diphosphate leaving group develops additional negative charge (24, 25). Bound magnesium is proposed to stabilize the negative charge buildup on the diphosphate moiety and activate the leaving group (21). Although magnesium is not absolutely required for FTase catalysis, millimolar concentrations of magnesium ions enhance the rate constant for product formation by 700-fold (24).Several pieces of experimental evidence indicate that the diphosphate of FPP forms part of the magnesium binding site. X-ray crystallography of the FTase ternary complex in the presence of manganese showed a manganese ion bo...